المؤلفون: Beat Bornhauser, Roland P. Kuiper, Steven M. Kornblau, Britt M.T. Vervoort, Jiangyan Yu, Rico Hagelaar, Fieke W Hoff, Frank N. van Leeuwen, Dorette van Ingen Schenau, Maria Pamela Dobay, Trisha M Tee, Laurens T. van der Meer, Silvia Jenni, Jules P.P. Meijerink, Jean-Pierre Bourquin, Miriam Butler

المساهمون: University of Zurich, van Leeuwen, Frank N

المصدر: Blood, 138(23), 2383-2395. AMER SOC HEMATOLOGY
Blood, 138, 23, pp. 2383-2395
Blood, 138, 2383-2395

مصطلحات موضوعية: Treatment response, Asparaginase, 1303 Biochemistry, Lymphoblastic Leukemia, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Immunology, 2720 Hematology, Antineoplastic Agents, Apoptosis, 610 Medicine & health, Biochemistry, 1307 Cell Biology, Mice, chemistry.chemical_compound, Piperidines, Cell Line, Tumor, Agammaglobulinaemia Tyrosine Kinase, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], Animals, Humans, CRISPR, Bruton's tyrosine kinase, Amino Acids, chemistry.chemical_classification, 2403 Immunology, biology, Adenine, Cell Biology, Hematology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Amino acid, chemistry, 10036 Medical Clinic, Ibrutinib, Cancer research, biology.protein, Tyrosine kinase, Signal Transduction

وصف الملف: application/pdf; blood_btk.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db47fa4b7f953cb27d3df3b78bffe81dTest
https://doi.org/10.1182Test/blood.2021011787

المؤلفون: Flora E. van Leeuwen, Jan de Boer, Augustinus D.G. Krol, Marieke W. J. Louwman, Berthe M.P. Aleman, Anna M. van Eggermond, Pieternella J. Lugtenburg, Judith M. Roesink, John M. M. Raemaekers, Josée M. Zijlstra, Michael Schaapveld, Leontien C. M. Kremer

المساهمون: Hematology, CCA - Innovative therapy, Other departments, Cancer Center Amsterdam, Amsterdam Reproduction & Development (AR&D), Paediatric Oncology

المصدر: van Eggermond, A M, Schaapveld, M, Lugtenburg, P J, Krol, A D G, de Boer, J P, Zijlstra, J M, Raemaekers, J M M, Kremer, L C M, Roesink, J M, Louwman, M W J, Aleman, B M P & van Leeuwen, F E 2014, ' Risk of multiple primary malignancies following treatment of Hodgkin lymphoma ', Blood, vol. 124, no. 3, pp. 319-327 . https://doi.org/10.1182Test/blood-2013-10-532184
Blood, 124(3), 319-327. American Society of Hematology
Blood, 124(3), 319-327
Blood, 124, 3, pp. 319-327; quiz 466
Blood, 124, 319-327; quiz 466

مصطلحات موضوعية: Oncology, medicine.medical_specialty, education.field_of_study, business.industry, Immunology, Hazard ratio, Population, Cell Biology, Hematology, Malignancy, medicine.disease, Biochemistry, Confidence interval, Surgery, Increased risk, Internal medicine, Cohort, medicine, Hodgkin lymphoma, Cumulative incidence, education, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0522015e7fabc9f9bb71a5a20c082238Test
https://doi.org/10.1182Test/blood-2013-10-532184